http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111777562-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
| filingDate | 2020-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111777562-B |
| titleOfInvention | 6-phenoxy substituted pyrimidine targeted DDR1 inhibitor, preparation method thereof and application of inhibitor in antitumor activity |
| abstract | The invention discloses a preparation method and an antitumor activity research of an N-substituted (5-chloro-6- (substituted phenoxy) pyrimidine-4-yl) benzamide DDR1 inhibitor capable of targeting DDR1, and test results show that the N-substituted (5-chloro-6- (substituted phenoxy) pyrimidine-4-yl) benzamide targeting DDR1 inhibitor has low toxicity to normal lung cells and has a good inhibition effect in a 10 mu M DDR1 kinase primary screen. |
| priorityDate | 2020-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.